锝亚甲基二膦酸盐注射液
时间:2015-02-02 06:04:57
云克系列
YUNKE SERIES
二十世纪九十年代公司成功研制的“云克”药物,是我国自六十年代起至今两个国产核素药物之一(其他核素药物均为进口或仿制药物)。
In 1990s ,the company developed the drug ‘YUNKE’ succeessfully. It is one of two nuclide drugs developed in our country since 1960s(the else all are imported or modeled medicaments).
“云克”是我国首个用于RA临床治疗的核素药物,并荣获国家发明专利(ZL94113006.1)以及“国家重点新产品”证书。
YUNKE is the first nuclide medicament to cure the rheumatoid arthritis. It awarded the government invention patent (ZL 94113006.1) and the certificate of ‘ State Important New Product’.
于2001年获得国家药品监督管理局的认可,可以作为普通药品在临床进行流通使用。
Certificated by SFDA in 2001, YUNKE could be used as common chemistry medicine in clinic.
通过与全国逾百家科研机构进行科研协作,对“云克”药物的治疗机理及临床疗效等进行了多方实验及临床验证:“云克”能通过独特的免疫调节机制,降低IL-1、IL-6、TNF-α、MMP3等多种标志性细胞因子水平,抑制破骨细胞活性,同时促进成骨细胞分裂增殖,从而修复骨侵蚀,恢复关节功能。
Through the scientific research cooperation with over 100 national institutions, it has been validated that YUNKE can reduce significant manifold cell level significant, include IL-1, IL-6, TNF-α, MMP3 and soon, by the unique mechanism to adjust the immunity function. Furthermore, it can recover the bone lacuna and joint function via prohibit activity of osteoclast and while facilitating the division osteoblast.
“云克”药物毒副作用少而轻微,比常用的Anti-RA药物毒性低。通过对部分患者长达三年的追踪发现,“云克”无一般Anti-RA药物引起的胃肠、肝肾方面的不良反应,也无致癌倾向。10万人次以上临床应用证明“云克”治疗类风湿性关节炎是非常安全的。
The side-effect of YUNKE was few and gentle than the common used Anti-RA drugs. Through follow up of part patients for 3 years, it was found that YUNKE has not side function to digestive system liver and kidney as common used Anti-RA drugs. The clinic uses of 100,000 patients proved YUNKE is very safe for RA treatment.
十年来的临床应用表明“云克”治疗类风湿性关节炎总有效率达85%以上,患者生活质量大幅度改善,部分瘫痪病人经过“云克”治疗后能在一定程度上恢复生活自理能力。
Over 10 years clinic uses, it was proved that the total cure rate was over 85%, the patients life quality improved greatly, part of labourless patients can do something by themselves in dayly life after treatment with YUNKE.
现普遍用于治疗类风湿性关节炎、强直性脊柱炎、甲亢突眼、肿瘤骨转移等免疫性疾病和骨性疾病。
YUNKE used broad to cure the immunity and bone disease, such as RA, AS, GO, ANFH and metastasis bone.